Literature DB >> 19037961

Allergic asthma: a tale of many T cells.

R Afshar1, B D Medoff, A D Luster.   

Abstract

Asthma is a common immune-mediated disorder characterized by reversible airway inflammation, mucus production, and variable airflow obstruction with airways hyperresponsiveness (AHR). In most cases the airway inflammation characteristic of asthma is thought to result from an allergic-type reaction to an inhaled substance from the environment (so-called allergic asthma). In allergic asthma, allergen exposure stimulates eosinophilic inflammation of the airways associated with infiltration of T cells. Although the recruitment of eosinophils into the airways is an important component in the pathogenesis of asthma, the trafficking of T lymphocytes into the airways is now believed to establish and orchestrate the asthmatic inflammatory response. This review explores the roles of various T cell subsets in the pathogenesis of allergic airway inflammation and highlights the contributions of these cells in regulating asthma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19037961     DOI: 10.1111/j.1365-2222.2008.03119.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  37 in total

1.  CARMA1 is necessary for optimal T cell responses in a murine model of allergic asthma.

Authors:  Ravisankar A Ramadas; Marly I Roche; James J Moon; Thomas Ludwig; Ramnik J Xavier; Benjamin D Medoff
Journal:  J Immunol       Date:  2011-11-09       Impact factor: 5.422

2.  Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation.

Authors:  Jorge L Medina; Jacqueline J Coalson; Edward G Brooks; Vicki T Winter; Adriana Chaparro; Molly F R Principe; Thirumalai R Kannan; Joel B Baseman; Peter H Dube
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01-26       Impact factor: 6.914

Review 3.  Developments in the field of allergy in 2009 through the eyes of Clinical and Experimental Allergy.

Authors:  H W Chu; C M Lloyd; W Karmaus; P Maestrelli; P Mason; G Salcedo; J Thaikoottathil; A J Wardlaw
Journal:  Clin Exp Allergy       Date:  2010-11       Impact factor: 5.018

4.  Imbalances of Th17 and Treg cells and their respective cytokines in COPD patients by disease stage.

Authors:  Xiang-Nan Li; Xue Pan; Dong Qiu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

5.  Anti-inflammatory effects of thiazolidinediones in human airway smooth muscle cells.

Authors:  Ming Zhu; Lesley Flynt; Sanjukta Ghosh; Matt Mellema; Audreesh Banerjee; Erin Williams; Reynold A Panettieri; Stephanie A Shore
Journal:  Am J Respir Cell Mol Biol       Date:  2010-09-24       Impact factor: 6.914

6.  α-Galactosylceramide treatment before allergen sensitization promotes iNKT cell-mediated induction of Treg cells, preventing Th2 cell responses in murine asthma.

Authors:  Qianhui Chen; Xuxue Guo; Nishan Deng; Linlin Liu; Shuo Chen; Ailing Wang; Ruiyun Li; Yi Huang; Xuhong Ding; Hongying Yu; Suping Hu; Hanxiang Nie
Journal:  J Biol Chem       Date:  2019-02-11       Impact factor: 5.157

Review 7.  The good, the bad and the ugly - TFH cells in human health and disease.

Authors:  Stuart G Tangye; Cindy S Ma; Robert Brink; Elissa K Deenick
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

8.  Dehydroepiandrosterone suppresses eosinophil infiltration and airway hyperresponsiveness via modulation of chemokines and Th2 cytokines in ovalbumin-sensitized mice.

Authors:  Chian-Jiun Liou; Wen-Chung Huang
Journal:  J Clin Immunol       Date:  2011-06-04       Impact factor: 8.317

Review 9.  Interleukin-17 regulation: an attractive therapeutic approach for asthma.

Authors:  Seoung Ju Park; Yong Chul Lee
Journal:  Respir Res       Date:  2010-06-16

Review 10.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.